Walgreens agreed Sept. 17 to settle a class-action lawsuit alleging it violated antitrust laws by restricting search advertisements, according to Digital News Daily.
Pharmacy
Sandoz, the generic arm of Novartis, is stopping worldwide distribution of its heartburn medicine that contains high levels of a cancer-causing impurity, according to STAT.
The FDA announced Sept. 17 a project that aims to give cancer patients access to cancer drugs at a quicker rate.
A class of commonly prescribed antibiotics, fluoroquinolones, cause an increased risk of heart valve problems, according to a new study published in the Journal of the American College of Cardiology.
Several U.S. senators sent a letter to the Federal Trade Commission asking it to closely scrutinize large pharmaceutical mergers and acquisitions according to STAT.
Although rebates for brand-name drugs in Medicare Part D substantially reduced drug spending, the rebates were not enough to offset major spikes in drug prices, according to a new study from Office of Inspector General cited by STAT.
Patients with a rare, but potentially fatal calcium-depleting disease are left in limbo with the recall of a critical medicine, according to NBC 5.
Federal narcotics agents from the Drug Enforcement Administration raided several Kaiser Permanente pharmacies along the West Coast Sept. 18, according to The Oregonian.
A vigil was held outside Eli Lilly's headquarters in Indianapolis Sept. 14 for people who have died from rationing their insulin, according to RTV6 Indianapolis.
Fitoterapia, a Miami.-based drugmaker, is recalling 19,000 bottles of its dietary supplement for sexual enhancement due to the presence of an active ingredient Tadalafil.